Oral Candidiasis: An Overview: Arun Singh, Renuka Verma, Aditi Murari, Ashutosh Agrawal
Oral Candidiasis: An Overview: Arun Singh, Renuka Verma, Aditi Murari, Ashutosh Agrawal
Oral Candidiasis: An Overview: Arun Singh, Renuka Verma, Aditi Murari, Ashutosh Agrawal
6]
REVIEW ARTICLE
INTRODUCTION • Chronic
• Erythematous
Fungi are free-living, eukaryotic organisms that exist as • Pseudomembranous
yeasts (round fungi), moulds (filamentous fungi), or a • Hyperplastic
combination of these two (dimorphic fungi). Oral candidiasis • Nodular
is one of the common fungal infection, affecting the oral • Plaque-like
mucosa. These lesions are caused by the yeast Candida • Candida-associated lesions
albicans. Candida albicans are one of the components of • Angular cheilitis
normal oral microflora and around 30% to 50% people carry • Denture stomatitis
this organism. Rate of carriage increases with age of the • Median rhomboid glossitis
patient. Candida albicans are recovered from 60% of dentate • Keratinized primary lesions superinfected with Candida
patient’s mouth over the age of 60 years. There are many • Leukoplakia
types of Candida species, which are seen in the oral cavity. • Lichen planus
[1,2] Species of oral Candida are: C. albicans, C. glabrata, C. • Lupus erythematosus.
guillermondii, C. krusei, C. parapsilosis, C. pseudotropicalis,
C. stellatoidea, C. tropicalis.[3] Secondary oral candidoses (Group II)
Pathogen
Access this article online
Quick Response Code:
Website: Candida is a fungus and was first isolated in 1844 from the
www.jomfp.in sputum of a tuberculosis patient. [5] Like other fungi, they are
non-photosynthetic, eukaryotic organisms with a cell wall
DOI: that lies external to the plasma membrane. There is a nuclear
10.4103/0973-029X.141325 pore complex within the nuclear membrane. The plasma
membrane contains large quantities of sterols, usually
ergosterol. Apart
[Downloaded free from http://www.jomfp.in on Wednesday, June 27, 2018, IP: 103.228.35.6]
from a few exceptions, the macroscopic and microscopic cultural syndrome, immunosuppressive conditions such as HIV
characteristics of the different candida species are similar. They infection, malignancies such as leukemia and nutritional
can metabolize glucose under both aerobic and anaerobic deficiencies – vitamin B deficiencies have been particularly
conditions. Temperature influences their growth with higher implicated.[14]
temperatures such as 37°C that are present in their potential
host, promoting the growth of pseudohyphae. They have been LABORATORY DIAGNOSIS OF ORAL
isolated from animals and environmental sources. They require
environmental sources of fixed carbon for their growth. CANDIDIASIS Specimen collection[15]
Filamentous growth and apical extension of the filament and
formation of lateral branches are seen with hyphae and mycelium The specimen should be collected from an active lesion; old
and single cell division is associated with yeasts. [6] Several ‘burned out’ lesions often do not contain viable organisms.
studies have demonstrated that infection with candida is
associated with certain pathogenic variables. Adhesion of candida Collect the specimen under aseptic conditions.
to epithelial cell walls, an important step in initiation of infection,
is promoted by certain fungal cell wall components such as Collect sufficient specimen.
mannose, C3d receptors, mannoprotein and saccharins.[7-9] Other
factors implicated are germ tube formation, presence of mycelia, Use sterile collection devices and containers
persistence within epithelial cells, endotoxins, induction of tumor
necrosis factor and proteinases.[10-12] Phenotypic switching which Label the specimen appropriately; all clinical specimens
is the ability of certain strains of C. albicans to change between should be considered as potential biohazards and should
different morphologic phenotypes has also been implicated.[13] be handled with care using universal precautions.
Pagano-Levin or Sabouraud’s agar, left in situ for the first 8 pouch for incubation. The O Yeast-I dent system is based
hours of 48 hours incubation at 37ºC. Then, the candidal on the use of chromogenic substances to measure enzyme
density at each site is determined by a Gallenkamp colony activities. Ricult-N dip slide technique is similar to, but of
counter and expressed as colony forming units per mm 2 (CFU higher sensitivity than MC system.[21]
mm-2 ).[16,17] Thus, it yields yeasts per unit mucosal surface. It
is useful for quantitative assessment of yeast growth in Histological identification
different areas of the oral mucosa and is thus useful in
localizing the site of infection and estimating the candidal Demonstration of fungi in biopsy specimens may require
load on a specific area (Budtz-Jorgensen, 1978, Olsen and several serial sections to be cut.[16] Fungi can be easily
Stenderup A, 1990).[16,18] demonstrated and studied in tissue sections with special
stains. The routinely used Hematoxylin and Eosin stain
Impression culture technique poorly stains Candida species. The specific fungal stains such
Taking maxillary and mandibular alginate impressions, as PAS stain, Grocott-Gomori’s methenamine silver (GMS)
transporting them to the laboratory and casting in 6% and Gridley stains are widely used for demonstrating fungi in
fortified agar with incorporated Sabouraud’s dextrose the tissues, which are colored intensely with these stains. [17]
broth. The agar models are then incubated in a wide
necked, sterile, screw-topped jar for 48-72 hours at 37ºC Physiological tests
and the CFU of yeasts estimated.[19]
The main physiological tests used in definitive
Saliva identification of Candida species involve determination of
This simple technique involves requesting the patient to their ability to assimilate and ferment individual carbon
expectorate 2 ml of mixed unstimulated saliva into a sterile, and nitrogen sources.[17,22]
universal container, which is then vibrated for 30 seconds on
a bench vibrator for optimal disaggregation. The number of The assimilation reactions and fermentation reactions of
Candida expressed as CFU/ml of saliva is estimated by Candida species are tabulated in Tables 1 and 2.
counting the resultant growth on Sabouraud’s agar using
either the spiral plating or Miles and Misra surface viable Phenotypic methods[22,23]
counting technique. Patients who display clinical signs of oral
candidiasis usually have more than 400 CFU/mL.[19] Serotyping
Serotyping is limited to the two serotypes (A and B), a fact
Oral rinse technique that makes it inadequate as an epidemiologic tool. It has
It was first described by Mckendrik, Wilson and Main recently been shown that there can be wide discrepancies in
(1967) and later modified by Samaranayake et al. (1968).[20] the results obtained with different methods of serotyping,
Table 4: Systemic antifungal medications human buccal epithelial cells. Infect Immun 1986;54:189-93.
of oropharyngeal candidiasis[4] 9. Douglas LJ. Surface composition and adhesion of Candida
albicans. Biochem Soc Trans 1985;13:982-4.
Generic name Formulation 10. Sobel JD, Muller G, Buckley HR. Critical role of germ tube
Amphotericin B 100 mg/ml oral suspension formation in the pathogenesis of candidal vaginitis. Infect Immun
Clotrimazole 10 mg troche 1984;44:576-80.
Fluconazole 100 mg tablet 11. Saltarelli CG, Gentile KA, Mancuso SC. Lethality of
10 mg/ml oral suspension candidal strains as influenced by the host. Can J Microbiol
40 mg/ml oral suspension 1975;21:648-54.
Itraconazole 100 mg capsule 12. Smith CB. Candidiasis: Pathogenesis, host resistance, and
10 mg/ml oral suspension predisposing factors. In: Bodey GP and Fainstein V, editors:
Candidiasis. New York: Raven Press; 1985.P. 53-70.
Ketoconazole 200 mg tablet
13. Slutsky B, Buffo J, Soll DR. High frequency switching of colony
Nystatin 100,000 units/ml oral suspension morphology in Candida albicans. Science 1985;230:666-9.
200,000 units/ml pastille 14. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J
500,000 units/ml tablet 2002;78:455-9.
100,000 units/ml vaginal table 15. Epstein JB, Pearsall NN, Truelove EL. Oral candidosis: Effects
of antifungal therapy upon clinical signs and symptoms, salivary
when a proper balance exists. Treatment of candida overgrowth antibody, and mucosal adherence of Candida albicans. Oral Surg
does not seek the eradication of candida from the diet or the Oral Med Oral Pathol 1981;51:32-6.
person, but rather a restoration of the proper and balanced 16. Olsen I, Stenderup A. Clinical – mycologic diagnosis of oral
ecological relationship between man and yeast. yeast infections. Acta Odontol Scand 1990;48:11-8.
17. Silverman Jr S. Laboratory diagnosis of oral candidosis. In:
Samaranayake LP, MacFarlane TW, editors. Oral Candidosis. 1 st
REFERENCES
ed. Cambridge: Butterwort; 1990. p. 213-37.
18. Budtz-Jorgensen E. Clinical aspects of Candida infection in
1. Terezhalmy GT, Huber MA. Oropharyngeal candidiasis:
denture wearers. J Am Dent Assoc 1978;96:474-9.
Etiology, epidemiology, clinical manifestations, diagnosis, and
19. Epstein JB, Pearsall NN, Truelove EL. Quantitative
treatment. Crest Oral-B at dentalcare.com Contin Educ Course relationships between candida albicans in saliva and the clinical
2011;1-16. status of human subjects. J Clin Microbiol 1980;12:475-6.
2. Prasanna KR. Oral candidiasis – A review. Scholarly J Med
20. Samaranayake LP. Nutritional factors and oral candidosis. J
2012;2:6-30.
Oral Pathol 1986;15:61-5.
3. Dangi YS, Soni MS, Namdeo KP. Oral candidiasis: A review.
21. Cutler JE, Friedman L, Milner KC. Biological and chemical
Int J Pharm Pharm Sci 2010;2:36-41.
characteristics of toxic substances from Candida albicans. Infect
4. Parihar S. Oral candidiasis- A review. Webmedcentral Dent
Immun 1972;6:616-27.
2011;2:1-18.
22. Sandven P. Laboratory identification and sensitivity testing of
5. Mandell GL, Bennett JE, Dolin R. Anti-fungal agents.
yeast isolates. Acta Odontal Scand 1990;48:27-36.
Principles and practice of infectious diseases. 4 th ed. New York: 23. McCullough MJ, Ross BC, Reade PC. Candida albicans: A
Churchill Livingstone; 1994. p. 401-10. review of its history, taxonomy, epidemiology, virulence
6. Lehmann PF. Fungal structure and morphology. Med Mycol
attributes, and methods of strain differentiation. Int J Oral
1998;4:57-8.
7. Brassart D, Woltz A, Golliard M, Neeser JR. In-vitro Maxillofac Surg 1996;25:136-44.
inhibition of adhesion of Candida albicans clinical isolates to human
buccal epithelial cells by Fuca1 ®2Galb-bearing complex carbohydrates. How to cite this article: Singh A, Verma R, Murari A, Agrawal A. Oral
Infect Immun 1991;59:1605-13. candidiasis: An overview. J Oral Maxillofac Pathol 2014;18:81-5.
8. Ghannoum MA, Burns GR, Elteen A, Radwan SS. Experimental Source of Support: Nil. Conflict of Interest: None declared.
evidence for the role of lipids in adherence of Candida spp to